New analysis from Scotland has found there may be a possible, though small, increased risk of developing a condition called idiopathic thrombocytopenic purpura (ITP) after administration of the Oxford/AstraZeneca Vaccine.
Doctors assure patients that the condition is treatable and often mild and it is more often seen in those who have pre-existing health conditions such as diabetes, heart disease or kidney disease.
The condition has also been seen in patients after taking other vaccines including the flu, MMR and hepatitis B.
Source: The Guardian, 9 June 2021
0
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now